Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in Shiraz-Iran

Indian Journal of Medical Microbiology

Volumn 25, Issue 4, 2007, Pages 374-377

  Kohanteb, J ^a   Bazargani, A ^a   Saberi Firoozi, M ^b   Mobasser, A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Agar dilution; Antimicrobial susceptibility test; Helicobacter pylori; Iran

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLARITHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; TETRACYCLINE;

ADOLESCENT; ADULT; AGAR DILUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; DUODENUM ULCER; ENDOSCOPY; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 37549044239     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.37342     Document Type: Article

References (20)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
2. Graham DY, Qureshi WA. Antibiotic resistance H. pylori infection and its treatment. Curr Pharm Des 2000;6:1537-44.
3. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and furazolidone in Brazil. Helicobacter 2000;5:79-83.
4. Hachem CY, Clarridge JE, Reddy R, Flamm R, Evans DG, Tanaka SK, et al. Antimicrobial susceptibility of Helicobacter pylori: Comparison of E-test, broth microdilution and disk diffusion for ampicillin, clarithromycin and metronidazole. Diagn Microbiol Infect Dis 1996;24:37-41.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, sixth informational supplement M100 59, 19, 1. National committee for Clinical Laboratory Standards: Villanova, PA; 1999.
6. Piccolomini R, Di Bonaventura G, Gatamo G, Carbone F, Neri M. Comparative evaluation of the E-test, agar dilution and broth dilution for susceptibility testing of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 1997;35:1842-6.
7. Siavoshi F, Pourkhajeh AH, Merat SH, Asl-Soleimani H, Heydarian E, Khatibian M, et al. Susceptibility of various strains of Helicobacter pylori to selected agents. Arch Iran Med 2000;3:60-3.
8. Perez Aldana L, Kato M, Nakagawa S, Kawarasaki M, Nagasako T, Mizushima T, et al. The relationship between consumption of antimicrobial agents and the prevalence primary Helicobacter pylori resistance. Helicobacter 2002;7:306-9.
9. Godoy AP, Riberio ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003;3:20.
10. Thyagarajan SP, Ray P, Das BK, Ayyagari A, Rajasambandam P, Ramathilagam B, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. J Gastroenterol Hepatol 2003;18:1373-8.
11. Axon AT. Helicobacter pylori therapy: Effect on peptic ulcer disease. J Gastroenterol Hepatol 1991;6:131-7.
12. Borody TJ, Shortis NP, Reyes E. Eradication therapies for Helicobacter pylori. J Gastroenterol 1998;33:53-6.
13. Destura RV, Labio ED, Barrett LJ, Alcantara CS, Gloria VI, Deaz ML, et al. Laboratory diagnosis and susceptibility of Helicobacter pylori infection in the Philippines. Ann Clin Microbiol Antimicrob 2004;3:25.
14. Nariman F, Eftekhar F, Habibi Z, Falsafi T. Anti-Helicobacter pylori activities of six Iranian plants. Helicobacter 2004;9:146-51.
15. Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the Pediatric Medical Center of Tehran, Iran. J Clin Microbiol 2004;42:387-9.
16. Mentis AF, Roma E, Pangalis A, Katsiyiannakis E. Susceptibilities of Helicobacter pylori strains isolated from children with gastritis to selected antibiotics. J Antimicrob Chemother 1999;44:720-2.
17. Wolle K, Leodolter A, Malfertheiner P, Konig W. Antibiotic susceptibility of Helicobacter pylori in Germany: Stable primary resistance from 1995 to 2000. J Med Microbiol 2002;51:705-9.
18. Torres J, Camorlinga-Ponce M, Perez-Perez G, Medrazo-De la Garza A, Dehesa M, Gonzalez-Valencia G, et al. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol 2001;39:2677-80.
19. Lind T, Megraud F, Unge P, Bayerdorffer E, O.marin C, Spiller R, et al. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999;116:248-53.
20. Fakheri H, Merat S, Hosseini V, Malekzadeh R. Low dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. Aliment Pharmacol Ther 2004;19:89-93.